Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
6,400
Employees6,400
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
6,400
Employees6,400

VRTX Key Statistics

Market cap
132.81B
Market cap132.81B
Price-Earnings ratio
31.14
Price-Earnings ratio31.14
Dividend yield
—
Dividend yield—
Average volume
1.50M
Average volume1.50M
High today
$533.25
High today$533.25
Low today
$522.91
Low today$522.91
Open price
$533.25
Open price$533.25
Volume
832.29K
Volume832.29K
52 Week high
$560.25
52 Week high$560.25
52 Week low
$403.16
52 Week low$403.16

Stock Snapshot

With a market cap of 132.81B, Vertex Pharmaceuticals(VRTX) trades at $523.41. The stock has a price-to-earnings ratio of 31.14.

On 2026-10-23, Vertex Pharmaceuticals(VRTX) stock traded between a low of $522.91 and a high of $533.25. Shares are currently priced at $523.41, which is +0.1% above the low and -1.8% below the high.

Vertex Pharmaceuticals(VRTX) shares are trading with a volume of 832.29K, against a daily average of 1.5M.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $403.16 at its lowest and $560.25 at its peak.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $403.16 at its lowest and $560.25 at its peak.

VRTX News

Barron's 1d
Vertex Pharmaceuticals Inc. Research & Ratings | VRTX - Barron's

...

Vertex Pharmaceuticals Inc. Research & Ratings | VRTX - Barron's
Simply Wall St 1d
Vertex Stock Could Be 32% Undervalued Despite New ALYFTREK Data

has delivered strong share-price gains in recent years, which puts a spotlight on whether the current US$524.52 level is supported by the cash the business can...

Vertex Stock Could Be 32% Undervalued Despite New ALYFTREK Data
The Motley Fool 5d
Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It

Warren Buffett has delivered warnings to Wall Street in recent years as the S&P 500 soared to new highs. In some cases, the warning came in the form of an incre...

Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It

Analyst ratings

77%

of 35 ratings
Buy
77.1%
Hold
17.1%
Sell
5.7%

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.